Aldevron announces expansion of mrna production capability

Will offer mrna cgmp production   from master cell bank to drug product made possible with precision nanosystems and cytiva   fargo, n.d. , may 1, 2023 /prnewswire/ -- aldevron, a leading global manufacturer of dna, rna and proteins used in cell and gene therapies and vaccine development, will expand its mrna production capabilities to include lipid nanoparticle (lnp) encapsulation and aseptic fill-finish capabilities enabling mrna cgmp manufacturing services from master cell bank through to drug product.
DHR Ratings Summary
DHR Quant Ranking